Download Infographic Overview Vaccine development starts by assessing unmet medical need, often with limited epidemiological data. A Target Product Profile (TPP) defines key vaccine characteristics and guides...
What is EUVABECO? The EUVABECO project — short for European Vaccination Beyond COVID-19 — is a major initiative funded under the EU4Health programme, aiming to translate lessons from the COVID-19 pandemic into durable...
The processes around vaccine licensure today are still built on a shared core: robust evidence for quality, safety, and efficacy, demonstrated through standardized preclinical testing, phased clinical trials, and...
Europe kicked off 2026 by adding more brains to the vaccine bureaucracy, designating a new WHO Collaborating Centre to help NITAGs turn messy evidence into cleaner policy decisions. In theory, this means fewer hand‑wavy...
Download Infographic Overview This infographic shows how vaccines help fight antimicrobial resistance (AMR) by preventing infections before antibiotics are needed. It presents a simple causal chain: fewer infections →...
Evidence from leading journals since 2021 consistently documents both pronounced vaccine inequity between countries and substantial within‑country access gaps, especially for COVID‑19 but also for routine childhood...
In the last days, there have been notable developments in COVID‑19 vaccine formulations, WHO prequalification, and – as reported before – politically driven schedule changes in the US. Very recent product...
Download Infographic Overview Vaccines contain active ingredients (antigens; mRNA) and inactive ingredients such as stabilizers, antimicrobials, inactivating agents, antibiotics, and residues from the production...